U.S. market Closed. Opens in 6 hours 2 minutes

BEAM | Beam Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue377.71M60.92M51.84M24.00K18.00KN/AN/A
Cost of Revenue20.01M22.58M16.44M103.18M5.41MN/AN/A
Gross Profit357.70M38.34M35.40M-103.16M-5.39MN/AN/A
Operating Expenses534.18M399.40M444.31M132.78M75.17M45.74M7.88M
Selling, General & Admin96.80M87.81M57.22M29.61M20.55M11.87M2.02M
Research & Development437.38M311.59M387.09M103.18M54.62M33.87M5.86M
Other Operating Expenses-437.38MN/AN/AN/A-71.00K-10.04MN/A
Operating Income-176.49M-338.48M-392.46M-132.76M-75.15M-45.74M-7.88M
Other Expenses / Income45.32M78.30M21.83M-61.83M-3.17M-71.29M-122.00K
Before Tax Income-131.16M-260.18M-370.64M-194.59M-78.33M-116.74M-8.00M
Income Tax Expenses1.37M3.41M-29.28M61.83M116.00K-71.00MN/A
Net Income-132.53M-263.59M-341.36M-256.42M-78.44M-115.26M-8.00M
Interest Expenses46.68M15.30M-9.00K1.57M187.00KN/AN/A
Basic Shares Outstanding77.15M70.02M64.23M46.73M51.34M35.14M12.95M
Diluted Shares Outstanding77.15M70.02M64.23M46.73M51.34M35.14M12.95M
EBITDA-156.47M-401.48M-414.30M-64.62M-69.24M16.16M-7.99M
EBITDA Margin-41.43%-659.03%-799.13%-269,270.83%-384,644.44%0.00%0.00%
EBIT-84.48M-244.88M-370.65M-193.02M-78.14M-186.25M-8.00M
EBIT Margin-22.37%-401.97%-714.93%-804,266.67%-434,105.56%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙